Suskova VS et al. |
[Immuno-modulating properties of a macrolide antibiotic "Z-factor"]. |
2003 |
Antibiot. Khimioter. |
pmid:15002174
|
Pisarev VV et al. |
[Comparative study of azithromycin pharmacokinetics in healthy volunteers in open cross randomized procedure]. |
2003 |
Antibiot. Khimioter. |
pmid:15004973
|
Bogdanov MB and Chernen'kaia TV |
[Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract]. |
2000 |
Antibiot. Khimioter. |
pmid:11212394
|
Budanov SV |
[Azithromycin (sumamed)--basic properties and therapy of community-acquired pneumonia]. |
2000 |
Antibiot. Khimioter. |
pmid:11212397
|
Iur'ev SIu et al. |
[Azithromycin levels in the chorion tissue within the first three months of the pregnancy term]. |
2004 |
Antibiot. Khimioter. |
pmid:15850052
|
Parry CM et al. |
Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17145784
|
Matlow A et al. |
Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593171
|
Donowitz GR and Earnhardt KI |
Azithromycin inhibition of intracellular Legionella micdadei. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285604
|
Strickman D et al. |
In vitro effectiveness of azithromycin against doxycycline-resistant and -susceptible strains of Rickettsia tsutsugamushi, etiologic agent of scrub typhus. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8585717
|
Bermudez LE et al. |
Stimulation with cytokines enhances penetration of azithromycin into human macrophages. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1667256
|
Rodvold KA et al. |
Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12878504
|
Dunne MW et al. |
Efficacy of single-dose azithromycin in treatment of acute otitis media in children after a baseline tympanocentesis. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12878537
|
Mulet X et al. |
Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19188376
|
Conte JE et al. |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807050
|
Nash KA and Inderlied CB |
Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807078
|
Neoh CF et al. |
Rapid and sensitive liquid chromatography/mass spectrometry assay for caspofungin in human aqueous humor. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20660672
|
Zhanel GG et al. |
Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16723591
|
Girgis NI et al. |
Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10348767
|
Wolf K and Malinverni R |
Effect of azithromycin plus rifampin versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10348778
|
Ngo LY et al. |
Pharmacokinetics of azithromycin administered alone and with atovaquone in human immunodeficiency virus-infected children. The ACTG 254 Team. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10348786
|
Wierzbowski AK et al. |
Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16251306
|
Jesus FP et al. |
In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25001300
|
Miura Y et al. |
Maternal intravenous treatment with either azithromycin or solithromycin clears Ureaplasma parvum from the amniotic fluid in an ovine model of intrauterine infection. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24982089
|
Waites KB et al. |
In Vitro Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27671057
|
Gillis RJ et al. |
Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16127063
|
RÃos AM et al. |
Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16127085
|
Berry V et al. |
Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15728883
|
GarcÃa-Quintanilla M et al. |
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27270288
|
Clark CL et al. |
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17876003
|
Köhler T et al. |
Ribosome protection prevents azithromycin-mediated quorum-sensing modulation and stationary-phase killing of Pseudomonas aeruginosa. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17876004
|
Yeruva L et al. |
Differential susceptibilities to azithromycin treatment of chlamydial infection in the gastrointestinal tract and cervix. |
2013 |
Antimicrob. Agents Chemother. |
pmid:24100498
|
Spangler SK et al. |
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192445
|
Stamler DA et al. |
Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192446
|
Reveneau N et al. |
Bactericidal activity of first-choice antibiotics against gamma interferon-induced persistent infection of human epithelial cells by Chlamydia trachomatis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15855497
|
Mizukane R et al. |
Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8203850
|
Perronne C et al. |
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1656860
|
Araujo FG and Remington JS |
Synergistic activity of azithromycin and gamma interferon in murine toxoplasmosis. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1656872
|
Fass RJ |
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8257127
|
Taylor DE and Chang N |
In vitro susceptibilities of Campylobacter jejuni and Campylobacter coli to azithromycin and erythromycin. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1659309
|
Wingard JB et al. |
A novel cell-associated protection assay demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21628536
|
Plouffe J et al. |
Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858333
|
Skindersoe ME et al. |
Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18644954
|
Jesus FP et al. |
In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26459895
|
Critchley IA et al. |
National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17908940
|
Salman S et al. |
Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic Modeling. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28242669
|
Unemo M et al. |
High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26077246
|
Bogdanovich T et al. |
Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16495248
|
Lai PC and Walters JD |
Azithromycin kills invasive Aggregatibacter actinomycetemcomitans in gingival epithelial cells. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23274657
|
Soares GM et al. |
Effects of azithromycin, metronidazole, amoxicillin, and metronidazole plus amoxicillin on an in vitro polymicrobial subgingival biofilm model. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25733510
|
Parry CM et al. |
Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25733500
|